These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15762347)

  • 1. Detection and measurement of microalbuminuria: a challenge for clinical chemistry.
    Busby DE; Atkins RC
    MLO Med Lab Obs; 2005 Feb; 37(2):8-9, 12, 14-6; quiz 18-9. PubMed ID: 15762347
    [No Abstract]   [Full Text] [Related]  

  • 2. The early diagnosis of glomerulopathy through the detection of subclinical proteinuria: microalbuminuria.
    Urizar RE; Cerda J; Godley K; Haenel C; Curtis G
    N Y State J Med; 1988 Aug; 88(8):423-6. PubMed ID: 3173828
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of microalbuminuria--what the nephrologist should know.
    Redon J
    Nephrol Dial Transplant; 2006 Mar; 21(3):573-6. PubMed ID: 16384822
    [No Abstract]   [Full Text] [Related]  

  • 4. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    McQueen MJ; Gerstein HC; Pogue J; Mann JF; Yusuf S
    Am J Kidney Dis; 2006 Dec; 48(6):889-96. PubMed ID: 17162143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on microalbuminuria as a biomarker in renal and cardiovascular disease.
    Lambers Heerspink HJ; Brinkman JW; Bakker SJ; Gansevoort RT; de Zeeuw D
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):631-6. PubMed ID: 17053479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of early determination of microalbuminuria in global vascular risk and diabetic nephropathy].
    de Alvaro F; Martínez Castelao A; Górriz JL
    Nefrologia; 2005; 25 Suppl 4():34-41. PubMed ID: 16392322
    [No Abstract]   [Full Text] [Related]  

  • 8. [Microalbuminuria as a biological marker for diagnosis of diabetic nephropathies].
    Matsuura M; Abe H; Doi T; Matsubara T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():346-51. PubMed ID: 15999732
    [No Abstract]   [Full Text] [Related]  

  • 9. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria: do we need a new threshold?
    Zamora CR; Cubeddu LX
    J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary albumin and cardiovascular profile in the middle-aged population.
    Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG
    Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What values should be used to diagnose microalbuminuria in patients with diabetes mellitus?].
    Leitão CB; Canani LH; Bolson PB; Molon MP; Silveiro SP; Gross JL
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):322-6. PubMed ID: 16767298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited commentary: evaluation of measures of urinary albumin excretion in epidemiologic studies.
    Dyer AR
    Am J Epidemiol; 2006 Oct; 164(8):728-30; discussion 731-2. PubMed ID: 16952930
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?
    Weir MR; Bakris GL
    Am J Nephrol; 2010; 31(5):469-70. PubMed ID: 20413964
    [No Abstract]   [Full Text] [Related]  

  • 15. Microalbuminuria in Type-1 diabetes mellitus.
    Redon J; Rodicio JL
    Blood Press; 2003; 12(5-6):349-50. PubMed ID: 14763669
    [No Abstract]   [Full Text] [Related]  

  • 16. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis.
    Krok KL; Milwalla F; Maheshwari A; Rankin R; Thuluvath PJ
    Liver Transpl; 2009 Sep; 15(9):1036-42. PubMed ID: 19718631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of an HPLC assay for urinary albumin.
    Owen WE; Roberts WL
    Am J Clin Pathol; 2005 Aug; 124(2):219-25. PubMed ID: 16040292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albuminuria in non-primary renal disease: risk marker rather than risk factor.
    de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2010 Mar; 25(3):656-8. PubMed ID: 20037170
    [No Abstract]   [Full Text] [Related]  

  • 20. [Test for microalbuminuria].
    Kumasaka K
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():540-5. PubMed ID: 12355805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.